GLP1-S 20mg

GLP1-S 20 mg (semaglutide) research material

Buy Semaglutide 20 mg for laboratory research, listed in this catalog as GLP1-S. It is supplied as lyophilized powder in one boxed 3 mL vial. The original laboratory report links the catalog label to the scientific name.

Compare the available vial sizes

Other presentations in this family are GLP1-S 5 mg, GLP1-S 10 mg. These options change the labeled quantity; choose the amount required for the planned laboratory work and check the records attached to the selected presentation.

This single-compound listing is distinct from the Cagrilintide + GLP1-S blend, which contains 5 mg of each component. A blend’s total milligram value is not the amount of GLP1-S alone.

What semaglutide development research examined

In Lau and colleagues’ original discovery study, researchers varied peptide substitutions and fatty-acid/linker chemistry while evaluating GLP-1 receptor potency and albumin affinity. The work illustrates how molecular modifications distinguish semaglutide from native GLP-1 and related analogs.

The published findings concern the authors’ study material and experimental conditions. They provide research context, not certification of this commercial lot, instructions for use or evidence of clinical equivalence.

When comparing a method with the supplied material, check the specified chemical form and modifications. Receptor activity, chromatographic purity and vial content answer separate questions.

Batch documentation and handling

Open COA & Documents and match the product and lot. Read the methods and reported identity, purity and measured content separately. A name or reference formula does not establish an unreported counterion or complete formulation.

The 20 mg value is the labeled amount of material; the 3 mL value is container capacity. Neither specifies a liquid concentration. Use applicable product records and laboratory procedures for storage and preparation.